Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Eli Lilly & Co. (NYSE:LLY)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

Eli Lilly & Co., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Short-term borrowings and current maturities of long-term debt 3.82 2.58 8.24 4.99 0.02
Accounts payable 3.58 3.22 3.14 3.48 3.76
Employee compensation 2.33 2.40 2.22 2.31 2.72
Sales rebates and discounts 12.56 11.44 9.93 10.09 7.20
Dividends payable 1.71 1.48 1.31 1.41 1.52
Income taxes payable 0.41 0.92 1.18 0.31 1.01
Other current liabilities 5.57 5.04 6.30 5.72 6.92
Current liabilities 29.97% 27.07% 32.32% 28.31% 23.14%
Long-term debt, excluding current maturities 35.17 26.51 22.10 21.56 22.41
Noncurrent operating lease liabilities 1.24 0.00 0.00 0.00 0.00
Accrued retirement benefits 9.41 6.63 7.81 6.32 6.07
Long-term income taxes payable 9.18 8.48 8.40 1.78 2.44
Other noncurrent liabilities 2.58 3.31 3.06 5.19 4.91
Deferred tax liabilities 5.57 3.14 0.38 0.56 0.00
Other liabilities 63.16% 48.08% 41.74% 35.40% 35.84%
Total liabilities 93.13% 75.15% 74.06% 63.72% 58.98%
Common stock, no par value 1.52 1.51 1.53 1.77 1.94
Additional paid-in capital 17.02 14.99 12.93 14.54 15.61
Retained earnings 12.52 25.95 30.89 41.35 45.02
Employee benefit trust -7.67 -6.86 -6.70 -7.76 -8.47
Accumulated other comprehensive loss -16.61 -13.05 -12.71 -13.59 -12.88
Cost of common stock in treasury -0.15 -0.16 -0.17 -0.21 -0.25
Total Eli Lilly and Company shareholders’ equity 6.64% 22.38% 25.77% 36.10% 40.97%
Noncontrolling interests 0.23 2.46 0.17 0.19 0.05
Total equity 6.87% 24.85% 25.94% 36.28% 41.02%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Eli Lilly & Co.’s current liabilities as a percentage of total liabilities and equity decreased from 2017 to 2018 but then increased from 2018 to 2019 not reaching 2017 level.
Other liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Eli Lilly & Co.’s other liabilities as a percentage of total liabilities and equity increased from 2017 to 2018 and from 2018 to 2019.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Eli Lilly & Co.’s total liabilities as a percentage of total liabilities and equity increased from 2017 to 2018 and from 2018 to 2019.
Total Eli Lilly and Company shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Eli Lilly & Co.’s total Eli Lilly and Company shareholders’ equity as a percentage of total liabilities and equity decreased from 2017 to 2018 and from 2018 to 2019.